Post Categories
Blog post not found!
QPS Neuropharmacology and Paracelsus Medical University (PMU) Announce Cooperation on a Parkinson’s Disease Research and Development Project
May 14, 2020
Parkinson’s disease (PD) is one of the most common neurodegenerative diseases, and the Parkinson’s Foundation estimates that 1.2 million people in the United States will…
Novel Coronavirus Testing: Part III
May 6, 2020
Antigen Testing Part I of this series on testing for the novel coronavirus covered the real-time reverse transcription polymerase chain reaction (rRT-PCR) assay, which…
Airborne Coronavirus Discovered in China – Could It Transmit the Novel Coronavirus?
May 6, 2020
Earlier this week, we discussed an aerosolized droplet study conducted by the University of Pennsylvania Perelman School of Medicine and the National Institutes of…
Aerosolized Droplet Study
April 29, 2020
Can the Novel Coronavirus Spread Through Speaking? There are conflicting opinions on whether the novel coronavirus, the virus that causes COVID-19, can be spread…
Novel Coronavirus Testing: Part II
April 27, 2020
Serology Testing “Test, test, test,” was the singular message from the World Health Organization’s Director-General Tedros Adhanom Ghebreyesus during remarks on the coronavirus pandemic…
Novel Coronavirus Testing: Part I
April 20, 2020
Real-Time Reverse Transcriptase Polymerase Chain Reaction Testing is the crucial first step to identifying and treating COVID-19. In the past few months, uncertainty has…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
NEWARK, Delaware, June 10, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new clinical…
NEWARK, Delaware, May 21, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), continues to expand and align its…
